-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How to Diagnose and Manage Antiphospholipid Syndrome

Program: Education Program
Session: Ongoing Challenges in the Management of VTE
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, autoimmune disorders, adult, Translational Research, Clinical Research, thromboembolism, pediatric, Diseases, Immune Disorders, real-world evidence, thrombotic disorders, young adult , Study Population, Human, Animal model
Saturday, December 9, 2023, 2:00 PM-3:15 PM

Keith R. McCrae, MD

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Disclosures: McCrae: Bristol Myers Squibb: Research Funding; Sanofi: Consultancy; Novartis: Consultancy; Alpine Biosciences: Consultancy.

OffLabel Disclosure: I will avoid trade names and any medication discussions will be based on the best available evidence

<< Previous Presentation | Next Presentation